AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of Emergent biosolutions, Inc. (EBS) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of Emergent biosolutions, Inc. (EBS) stock worth $1K-$15K in a STOCK Act filing on Nov 15, 2021.
The trade happened on Oct 18, 2021, 28 days before it was made public.
EBS has moved -87.4% since the trade date, from $50.41 to $6.33 (Oct 2, 2026 close).
- Traded
- Oct 18, 2021
- Disclosed
- Nov 15, 2021
- Filing delay
- 28 days
- Price since
- -87.4%
- Source
- STOCK Act disclosure
Other trades in this disclosure (44)
- BuyMSFT$15K-$50KNov 15, 2021
- BuyNTDOY$15K-$50KNov 15, 2021
- BuyAAPL$1K-$15KNov 15, 2021
- BuyAFRM$1K-$15KNov 15, 2021
- BuyAMD$1K-$15KNov 15, 2021
- BuyBHP$1K-$15KNov 15, 2021
- BuyBIIB$1K-$15KNov 15, 2021
- SellBMRN$1K-$15KNov 15, 2021
- BuyBX$1K-$15KNov 15, 2021
- BuyCVET$1K-$15KNov 15, 2021
- SellDASTY$1K-$15KNov 15, 2021
- BuyDAVA$1K-$15KNov 15, 2021
- SellDE$1K-$15KNov 15, 2021
- SellDE$1K-$15KNov 15, 2021
- SellEL$1K-$15KNov 15, 2021
- BuyETSY$1K-$15KNov 15, 2021
- SellFB$1K-$15KNov 15, 2021
- SellFB$1K-$15KNov 15, 2021
- SellFB$1K-$15KNov 15, 2021
- SellFDX$1K-$15KNov 15, 2021
More EBS insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.